StockWatch
·
Personal Care
Board Meeting2 Nov 2026, 06:42 pm

JHS Svendgaard Board Approves Unaudited Financial Results

AI Summary

JHS Svendgaard Laboratories Ltd announced that its Board of Directors, in a meeting held on November 2, 2026, approved the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The board also approved the appointment of Mr. Pardeep Kumar Bhardwaj as an Additional (Non-Executive Independent) Director. The financial results were accompanied by a limited review report. The meeting commenced at 3:00 PM and concluded at 4:30 PM. This information will be made available on the company's website.

Key Highlights

  • Board approved unaudited standalone and consolidated financial results.
  • Results are for the quarter and half-year ended September 30, 2026.
  • Appointment of Mr. Pardeep Kumar Bhardwaj as Additional Director approved.
  • Limited Review Report on financial results also approved.
  • Financials will be available on the company website.